Overview
SCTX market data
Price History
SCTX price chart · 1M
- O
- 32.12
- H
- 33.36
- L
- 29.40
- C
- 31.99
- Vol
- 6,069.00
- Source
- US equities market feed
- Observed
- Aug 26, 2026, 12:00 AM
- Cadence
- Five-minute page cache; daily and stored hourly bars
- Status
- fresh
Key Stats & Performance
- Open
- $32.12
- Previous Close
- $31.26
- Day High
- $33.36
- Day Low
- $29.40
- 52 Week High
- $39.20
- 52 Week Low
- $17.37
- 7 Day Return
- +2.68%
- 30 Day Return
- +69.62%
- 90 Day Return
- +42.78%
- 1 Year Return
- +42.78%
- Daily Notional Volume
- $194.1K Latest daily bar volume multiplied by its closing price.
Valuation & Profitability
- P/E (TTM)
- — Trailing twelve-month price-to-earnings ratio. Higher means the market is pricing in more growth. Negative or missing when earnings are negative.
- Forward P/E
- — P/E based on consensus forward EPS estimates. Lower versus trailing implies expected earnings growth.
- EPS (TTM)
- — Diluted earnings per share over the trailing twelve months.
- Beta
- -3.95 Volatility relative to the index. 1.00 equals market, above 1 amplifies the broad-market move, below 1 dampens it.
- Dividend Yield
- — Annual dividend per share divided by current price. Zero or blank when the company does not pay a dividend.
- Profit Margin
- — Net income divided by revenue. Comparable within a sector, less so across sectors.
- 52w range
- $17.31 – $39.60 Lowest and highest closing prices over the past 52 weeks.
- Analyst Target
- — Mean of sell-side analyst 12-month price targets. Use as a sentiment gauge; targets are biased upward in aggregate.
Display-only. Refreshed once per symbol per 24 hours · market cap —.
Company News
Napco Security Technologies Posts Upbeat Q4 Results, Joins Alvotech, Rum Group And Other Big Stocks Moving Higher On MondayBenzinga · Aug 24, 2026, 2:22 PM
Deere, Coinbase Global, Nordson And Other Big Stocks Moving Higher On WednesdayBenzinga · Aug 20, 2026, 3:06 PM
Scribe Therapeutics shares are trading higher after multiple analyst firms initiated coverage on the stock with their respective ratings and price targets.Benzinga · Aug 18, 2026, 2:33 PM
Wells Fargo Initiates Coverage On Scribe Therapeutics with Overweight Rating, Announces Price Target of $60Benzinga · Aug 18, 2026, 1:21 PM
Leerink Partners Initiates Coverage On Scribe Therapeutics with Outperform Rating, Announces Price Target of $37Benzinga · Aug 18, 2026, 12:36 PM
Guggenheim Initiates Coverage On Scribe Therapeutics with Buy Rating, Announces Price Target of $50Benzinga · Aug 18, 2026, 12:21 PM
8-K filing — Scribe Therapeutics, Inc. (SCTX)SEC EDGAR · Jul 27, 2026, 9:08 PM
Trading Halt: Halt status updated at 10:10:00 AM ET: Quotation Resumption: IPO security released for quotationBenzinga · Jul 24, 2026, 2:10 PM
Reported Earlier, Scribe Therapeutics Prices Upsized Initial Public Offering Of 8,580,000 Common Shares At $15.00 Per Share, Expects $128.7M In Gross ProceedsBenzinga · Jul 24, 2026, 7:11 AM